Whilst the expression of the FLT1 gene is reported to be altered in the placenta of women with GDM, previous work has not evaluated whether sFLT1 levels are altered and could serve as a biomarker for GDM pregnancies. The gene discussed is FLT1; the disease is gestational diabetes.